Treatment of Ancylostomiasis and Ascariasis with Albendazole

摘要

In the present study, using the same methods of the double-blind study to assess intensity of infection and results of therapy, we treated an additional 63 patients with Albendazole. The drug regimen for the total 93 cases studied was as follows: 49 patients were treated with a single dose of 400 mg Albendazole and a further 44 with 200 mg daily for three days. The Table shows the results. Of 35 patients with ancylostomiasis who received the single dose, 30 were cured; of 14 with ascariasis, 13 were cured. In the group of patients treated for three days all except one of the 32 patients with hookworm were cured while all 12 with roundworm were cured. Egg reduction was better than 78% in all patients who remained infected after treatment. No adverse reactions occurred in any of the patients treated with Albendazole.